Editorial: The future of physiology: 2020 and beyond, Volume III

por Imig, John D.
Publicado 2023

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension

por Imig, John D.
Publicado 2023

Diabetes risk associated with plasma epoxylipid levels

por Imig, John D.
Publicado 2021

SARS-CoV-2 spike protein causes cardiovascular disease independent of viral infection

por Imig, John D.
Publicado 2022

Frontiers in metabolic physiology grand challenges

por Imig, John D.
Publicado 2022

Afferent arteriolar responses to β,γ-methylene ATP and 20-HETE are not blocked by ENaC inhibition

por Nagasawa, Tasuku, Imig, John D
Publicado 2013

Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors

por Imig, John D., Morisseau, Christophe
Publicado 2020

Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors

por Pavlov, Tengis S., Imig, John D., Staruschenko, Alexander
Publicado 2010

Editorial: Nuclear receptors in hemodynamics and blood pressure control

por Imig, John D., Wu, Jing, Gohar, Eman Y.
Publicado 2023

The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension

por Imig, John D., Carpenter, Margaret A., Shaw, Sean
Publicado 2009

Multi-Target Approaches in Metabolic Syndrome

por Lillich, Felix F., Imig, John D., Proschak, Ewgenij
Publicado 2021

Editorial: Renal Function in Acute and Chronic Kidney Diseases

por Imig, John D., Hye Khan, Md Abdul, Zhao, Xueying
Publicado 2020

Renal AT(1) Receptor Protein Expression During the Early Stage of Diabetes Mellitus

por Harrison-Bernard, Lisa M., Imig, John D., Carmines, Pamela K.
Publicado 2002

Editorial: Interactions Between Podocytes, Mesangial Cells, and Glomerular Endothelial Cells in Glomerular Diseases

por Imig, John D., Zhao, Xueying, Elmarakby, Ahmed A., Pavlov, Tengis
Publicado 2022

Tim-1 Deficiency Aggravates High-Fat Diet-Induced Steatohepatitis in Mice

por George, Jasmine, Zhang, Yuanyuan, Sloan, Jacob, Sims, Joya M., Imig, John D., Zhao, Xueying
Publicado 2021

Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice

por Hye Khan, Md. Abdul, Stavniichuk, Anna, Sattar, Mohammad Abdul, Falck, John R., Imig, John D.
Publicado 2019

Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats

por Walkowska, Agnieszka, Červenka, Luděk, Imig, John D., Falck, John R., Sadowski, Janusz, Kompanowska-Jezierska, Elżbieta
Publicado 2021

Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury

por Hye Khan, Md. Abdul, Falck, John R., Manthati, Vijaya L., Campbell, William B., Imig, John D.
Publicado 2014

Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity

por Imig, John D., Hye Khan, Md Abdul, Burkhan, Anna, Chen, Guan, Adebesin, Adeniyi Michael, Falck, John R.
Publicado 2021

Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure

por Vacková, Šárka, Kikerlová, Soňa, Melenovsky, Vojtěch, Kolář, František, Imig, John D., Kompanowska-Jezierska, Elzbieta, Sadowski, Janusz, Červenka, Luděk
Publicado 2019